INTRODUCTION
============

Polyglutamine (PolyQ) repeats are implicated in several neurodegenerative diseases, including Huntington's disease and several spinocerebellar ataxia's. It is commonly thought that a toxic gain-of-function mechanism is triggered by the presence of a polyQ tract, involving a conformational change within the protein and the formation and deposition of β-sheet rich amyloid-like fibrils ([@B1; @B2; @B3]).

The length of the polyQ repeat is critical to pathogenesis; however, there is evidence that other protein factors, including the location, type and number of flanking domains can modulate pathogenesis ([@B4; @B5; @B6; @B7; @B8; @B9; @B10]). Although there are many human polyQ-containing proteins ([@B11]), only nine polyQ-containing proteins are implicated in pathogenesis, and the precise repeat threshold to pathogenesis varies within the disease subset, for example, a 37 glutamine repeat is sufficient to lead to Huntington\'s disease, while SCA3 results only when the polyQ repeat expands to 45 or greater ([@B12; @B13; @B14]).

Many other human, non-disease related proteins contain polyQ repeats, which are intrinsically prone to expansion at the genetic level ([@B11],[@B15],[@B16]). In fact, a 40 glutamine repeat is the normal allele present in forkhead box P2 transcription factor; a protein that has not been found to be associated with a polyQ disease ([@B17],[@B18]). This evidence has led to the hypothesis that protein characteristics modulate the propensity of polyQ-containing proteins to aggregate and cause disease. To investigate the variable characteristics of polyQ proteins we have performed a bioinformatics investigation of the protein context of polyglutamine repeats, and constructed a web-accessible database of all human proteins containing a polyQ repeat greater than seven glutamines in length, termed 'PolyQ'. The PolyQ database provides a tool to compare the polyQ repeat location, the occurrence/type of domains and the number of domain repeats present across disease and non-disease proteins.

PolyQ DESCRIPTION AND USE
=========================

PolyQ was created using open-source MySQL relational database server software, version 5.0.82 (<http://www.mysql.com>), running on an Apple 8-core 3.0 GHz Xeon/OS X Server (version 10.5.8). The database consists of three tables. A web-based query interface to the database was developed using the PHP5 programming language, hosted via Apache 2.2.14. The user interface was developed with the utilisation of the JQuery Javascript library and JQuery widgets. Charts and graphs are constructed on the fly using the Google Visualization API.

The PolyQ database was populated by extracting all human sequences from the NCBI non-redundant (NR) database that contained at least seven consecutive glutamine residues. We then performed a Pfam ([@B19]) domain search to find protein domains within this subset of sequences. The NCBI NR contains many versions of the same protein, which created bias in the statistical analysis of PolyQ location data. We simplified the analysis by indentifying protein variants/isoforms and using only the longest protein isoforms (which we termed 'master sequences'), therefore eliminating splice variants/protein fragments. Multiple variants/isoforms of each protein were crudely identified by comparing the protein sequence following the PolyQ chains. The original sequences were then subjected to the BLASTClust ([@B20]), FORCE ([@B21]), MCL ([@B22]) and HomoClust algorithms ([@B23]), and the variants/isoforms were adjusted as necessary. The crude identification used the 10 amino acids immediately after the PolyQ chain as a 'search string'; any sequence that had the 10 amino acids immediately following its own polyQ chain was presumed to have homology with that sequence. The homology groups were confirmed by analyzing the data using the above algorithms. This yielded a total of 128 master sequences, from an original data set of \>700 polyQ-containing human protein sequences.

The database can be searched according to protein name, Pfam domain or sequence. The results of a typical search, shown in [Figure 1](#F1){ref-type="fig"}A, show both a graphical summary ([Figure 1](#F1){ref-type="fig"}A, top) and textual details ([Figure 1](#F1){ref-type="fig"}A, bottom) according to sequence classification (see below). The graphical summary shows pie chart and bar chart representations of the results according to sequence classification ([Figure 1](#F1){ref-type="fig"}A, top), Pfam domain occurrence ([Figure 1](#F1){ref-type="fig"}B) and Pfam domain repetition ([Figure 1](#F1){ref-type="fig"}C). Retrieved database entries are listed in table format with one row per protein, and three columns containing protein name (with links to the GenBank entry), Pfam domains, and protein sequence (with the polyQ region annotated), respectively. Homologs in the database can be included or excluded from the search. From this view, the domain and sequence context of the polyQ sequence can be identified and further interrogated. To aid analysis specific entries can be selected from the results (using the 'examine' button) and grouped together. Figure 1.(**A**) Typical results of a simple search (blank in this instance), showing graphical breakdown according to sequence classification; Results shown graphically according to domain occurrence (**B**) and domain repeats (**C**) using the tabs at top of page \[as seen in (A)\].

Sequence classification
-----------------------

The data are sorted and annotated according to the following sequence classifications: *N-Terminal PolyQs*---sequences where the first polyQ chain appears before all Pfam domains; *C-Terminal PolyQs*---sequences where the last polyQ chain appears after all Pfam domains; *Interdomain PolyQs*---sequences where the polyQ chains appear between the first Pfam domain and the last Pfam domain; *Mid Domain PolyQs*---sequences in which the polyQ chain appears in the middle of a Pfam domain, or overlaps a Pfam domain; *No Significant Domain PolyQs*---sequences that do not contain any significant Pfam domains; *Unclassified PolyQs*---sequences that did not fit into any of the above classifications. Each group is readily accessed using the tabs in the web page ([Figure 1](#F1){ref-type="fig"}A). We have also further reduced the redundancy in the data by clustering sequence homologs, and have also tagged known disease proteins.

Domain occurrence, repeats and disease statistics
-------------------------------------------------

The website features pre-constructed pages that show the database entries sorted according to non-disease and disease-causing proteins respectively. This distinction is applied to the sequence classifications above, the domain occurrence (e.g. listing all domains, [Figure 1](#F1){ref-type="fig"}B), and domain repeats ([Figure 1](#F1){ref-type="fig"}C). This allows database entries to be grouped and examined according to whether the polyQ tracts are found in non-disease or disease-causing proteins ([Figure 2](#F2){ref-type="fig"}). Figure 2.Selecting the 'Stats' menu text shows the entire database contents to be grouped into non-disease and disease causing proteins. To aid analysis specific entries can be selected (indicated by a tickbox), using the 'examine' button and grouped together.

CONCLUSIONS AND FUTURE DIRECTIONS
=================================

PolyQ is a valuable resource for theoreticians and experimentalists looking for insights into the context of PolyQ repeats in proteins and relationships with disease. Although the query tool allows searching across much of the database, we are developing a custom interface that will allow user-configurable queries against the whole data set as well as user customization of how the results are displayed. We are also adding the structural information \[e.g. from the SCOP ([@B24]), CATH ([@B25]) and PDB databases ([@B26])\] to the resources such that the structural context of polyQ repeats can be investigated.
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